Effect of Type-I Interferon on Retroviruses

被引:15
|
作者
Gomez-Lucia, Esperanza [1 ]
Collado, Victorio M. [1 ]
Miro, Guadalupe [1 ]
Domenech, Ana [1 ]
机构
[1] Univ Complutense, Dept Sanidad Anim, Fac Vet, E-28040 Madrid, Spain
来源
VIRUSES-BASEL | 2009年 / 1卷 / 03期
关键词
Type-I interferons; retrovirus; HIV-1; HTLV-I; FeLV; MuLV; ISRE; PLASMACYTOID DENDRITIC CELLS; FELINE IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MURINE LEUKEMIA-VIRUS; OVINE LENTIVIRUS REPLICATION; PRIMARY HIV-1 INFECTION; TOLL-LIKE-RECEPTORS; ALPHA-INTERFERON; IFN-ALPHA; T-CELLS;
D O I
10.3390/v1030545
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type-I interferons (IFN-I) play an important role in the innate immune response to several retroviruses. They seem to be effective in controlling the in vivo infection, though many of the clinical signs of retroviral infection may be due to their continual presence which over-stimulates the immune system and activates apoptosis. IFN-I not only affect the immune system, but also operate directly on virus replication. Most data suggest that the in vitro treatment with IFN-I of retrovirus infected cells inhibits the final stages of virogenesis, avoiding the correct assembly of viral particles and their budding, even though the mechanism is not well understood. However, in some retroviruses IFN-I may also act at a previous stage as some retroviral LTRs posses sequences homologous to the IFN-stimulated response element (ISRE). When stimulated, ISREs control viral transcription. HIV-1 displays several mechanisms for evading IFN-I, such as through Tat and Nef. Besides IFN-alpha and IFN-beta, some other type I IFN, such as IFN-tau and IFN-omega, have potent antiviral activity and are promising treatment drugs.
引用
收藏
页码:545 / 573
页数:29
相关论文
共 50 条
  • [41] Exhaustion of type-I interferon response following an acute viral infection
    Alsharifi, M
    Lobigs, M
    Regner, M
    Koskinen, ELA
    Müllbacher, A
    TISSUE ANTIGENS, 2005, 66 (05): : 345 - 346
  • [42] INDUCTION OF SV40 EARLY TRANSCRIPTION BY TYPE-I INTERFERON
    TZEN, CY
    SCOTT, RE
    EXPERIMENTAL CELL RESEARCH, 1993, 205 (02) : 246 - 250
  • [43] ATYPICAL SPI INTERFERON BINDS ON PORCINE CELLS TO A MAJOR COMPONENT OF TYPE-I INTERFERON RECEPTOR
    NIU, PD
    LEFEVRE, F
    LABONNARDIERE, C
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (09): : 769 - 775
  • [44] INHIBITION OF MURINE OSTEOGENIC SARCOMAS BY TREATMENT WITH TYPE-I OR TYPE-II INTERFERON
    CRANE, JL
    GLASGOW, LA
    KERN, ER
    YOUNGNER, JS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 61 (03) : 871 - 874
  • [45] Josephson effect in type-I Weyl semimetals
    Sinha, Debabrata
    PHYSICAL REVIEW B, 2020, 102 (08)
  • [46] EFFECT TESTOSTERONE ON TYPE-I DIABETES DEVELOPMENT
    TAKEI, S
    FORMBY, B
    TOYODA, H
    FASEB JOURNAL, 1995, 9 (04): : A785 - A785
  • [47] ANTIVIRAL ACTIVITY OF AUTOCRINE INTERFERON-BETA REQUIRES THE PRESENCE OF A FUNCTIONAL INTERFERON TYPE-I RECEPTOR
    ROUSSEAU, V
    CREMER, I
    LAURET, E
    RIVIERE, I
    AGUET, M
    DEMAEYER, E
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (09): : 785 - 789
  • [48] DIFLUOROMETHYLORNITHINE PREVENTS THE DOWN-REGULATION OF TYPE-I INTERFERON RECEPTORS - A POSSIBLE MECHANISM FOR A SYNERGISTIC ANTIPROLIFERATIVE EFFECT
    DILOLLO, DL
    BEILHARZ, MW
    LAI, MC
    MINCHIN, RF
    MOLECULAR PHARMACOLOGY, 1990, 38 (04) : 451 - 454
  • [49] SHARED ARCHITECTURE OF HORMONE BINDING DOMAINS IN TYPE-I AND TYPE-II INTERFERON RECEPTORS
    BAZAN, JF
    CELL, 1990, 61 (05) : 753 - 754
  • [50] INTERFERON RESPONSIVENESS OF NATURAL-KILLER CELLS IN TYPE-I HUMAN DIABETES
    NEGISHI, K
    GUPTA, S
    CHANDY, KG
    WALDECK, N
    KERSHNAR, A
    BUCKINGHAM, B
    CHARLES, MA
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1988, 7 (01): : 49 - 52